Chiesi Global Rare Diseases Announces Health Canada Grants Priority Review for FILSUVEZ (birch triterpenes) Topical Gel for the Treatment of Epidermolysis Bullosa (The Manila Times) - Jun 9, 2026 - "The submission is supported by data from the pivotal Phase 3 trial, EASE..."
Canada filing • Priority review • Dermatology
|